Matches in SemOpenAlex for { <https://semopenalex.org/work/W2803294938> ?p ?o ?g. }
- W2803294938 endingPage "2182" @default.
- W2803294938 startingPage "2173" @default.
- W2803294938 abstract "Increased risk of herpes zoster (HZ) has been observed in patients with immune-mediated diseases, including rheumatoid arthritis (RA), psoriasis (PsO), and inflammatory bowel disease; this risk can be further increased by the use of immunosuppressive therapy. One advancing modality of therapy for these diseases is Janus kinase (JAK) inhibition. Tofacitinib is an oral JAK inhibitor for the treatment of RA and psoriatic arthritis, which is currently under investigation for the treatment of ulcerative colitis (UC) and was previously investigated for psoriasis. JAK inhibitors have been associated with HZ events in patients across a number of indications. The pathogenesis underlying this risk of HZ is currently unknown. An increased risk of HZ has been noted in patients receiving immunosuppressive therapies for UC, including tofacitinib. In clinical trials, there was a dose-dependent risk of HZ (higher dose linked with increased risk). However, the majority of HZ cases are nonserious and noncomplicated, mild to moderate in severity, and manageable without permanent discontinuation of treatment. This review will discuss HZ risk in patients receiving JAK inhibitors, focusing on tofacitinib with respect to the potential mechanisms and epidemiology of HZ. Current guidelines for the prevention of HZ will be highlighted, and proposed management reviewed." @default.
- W2803294938 created "2018-06-01" @default.
- W2803294938 creator A5015470174 @default.
- W2803294938 date "2018-05-17" @default.
- W2803294938 modified "2023-10-16" @default.
- W2803294938 title "Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention" @default.
- W2803294938 cites W1118293217 @default.
- W2803294938 cites W116752814 @default.
- W2803294938 cites W1547943993 @default.
- W2803294938 cites W1604305908 @default.
- W2803294938 cites W1825495625 @default.
- W2803294938 cites W1916256274 @default.
- W2803294938 cites W1925361523 @default.
- W2803294938 cites W1930140134 @default.
- W2803294938 cites W1977548043 @default.
- W2803294938 cites W1981815093 @default.
- W2803294938 cites W1982821280 @default.
- W2803294938 cites W1995673905 @default.
- W2803294938 cites W2002408751 @default.
- W2803294938 cites W2010207831 @default.
- W2803294938 cites W2013100716 @default.
- W2803294938 cites W2040947756 @default.
- W2803294938 cites W2046628605 @default.
- W2803294938 cites W2056690858 @default.
- W2803294938 cites W2058409077 @default.
- W2803294938 cites W2075994714 @default.
- W2803294938 cites W2086454732 @default.
- W2803294938 cites W2086658590 @default.
- W2803294938 cites W2092863985 @default.
- W2803294938 cites W2096464703 @default.
- W2803294938 cites W2097302763 @default.
- W2803294938 cites W2097985774 @default.
- W2803294938 cites W2104543475 @default.
- W2803294938 cites W2104666226 @default.
- W2803294938 cites W2107210055 @default.
- W2803294938 cites W2113550278 @default.
- W2803294938 cites W2117625373 @default.
- W2803294938 cites W2123910593 @default.
- W2803294938 cites W2124998973 @default.
- W2803294938 cites W2142004396 @default.
- W2803294938 cites W2143556794 @default.
- W2803294938 cites W2145593067 @default.
- W2803294938 cites W2146768400 @default.
- W2803294938 cites W2146890931 @default.
- W2803294938 cites W2151734278 @default.
- W2803294938 cites W2159195400 @default.
- W2803294938 cites W2162805528 @default.
- W2803294938 cites W2163184895 @default.
- W2803294938 cites W2164327378 @default.
- W2803294938 cites W2169983987 @default.
- W2803294938 cites W2200225893 @default.
- W2803294938 cites W2272632494 @default.
- W2803294938 cites W2292426599 @default.
- W2803294938 cites W2308059048 @default.
- W2803294938 cites W2312847320 @default.
- W2803294938 cites W2338472944 @default.
- W2803294938 cites W2339193824 @default.
- W2803294938 cites W2508769609 @default.
- W2803294938 cites W2518284609 @default.
- W2803294938 cites W2519957152 @default.
- W2803294938 cites W252068646 @default.
- W2803294938 cites W2525212149 @default.
- W2803294938 cites W2556359407 @default.
- W2803294938 cites W2559743688 @default.
- W2803294938 cites W2559774515 @default.
- W2803294938 cites W2559845611 @default.
- W2803294938 cites W2561041192 @default.
- W2803294938 cites W2566103724 @default.
- W2803294938 cites W2571140916 @default.
- W2803294938 cites W2572824518 @default.
- W2803294938 cites W2584337339 @default.
- W2803294938 cites W2593565645 @default.
- W2803294938 cites W2606279260 @default.
- W2803294938 cites W2626892937 @default.
- W2803294938 cites W2734390848 @default.
- W2803294938 cites W2748091531 @default.
- W2803294938 cites W2749644585 @default.
- W2803294938 cites W2749941863 @default.
- W2803294938 cites W2807009918 @default.
- W2803294938 cites W4211138554 @default.
- W2803294938 cites W4229808289 @default.
- W2803294938 cites W4293777482 @default.
- W2803294938 doi "https://doi.org/10.1093/ibd/izy150" @default.
- W2803294938 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6140435" @default.
- W2803294938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29788127" @default.
- W2803294938 hasPublicationYear "2018" @default.
- W2803294938 type Work @default.
- W2803294938 sameAs 2803294938 @default.
- W2803294938 citedByCount "77" @default.
- W2803294938 countsByYear W28032949382018 @default.
- W2803294938 countsByYear W28032949382019 @default.
- W2803294938 countsByYear W28032949382020 @default.
- W2803294938 countsByYear W28032949382021 @default.
- W2803294938 countsByYear W28032949382022 @default.
- W2803294938 countsByYear W28032949382023 @default.
- W2803294938 crossrefType "journal-article" @default.
- W2803294938 hasAuthorship W2803294938A5015470174 @default.
- W2803294938 hasBestOaLocation W28032949381 @default.